Clinical Trial Update: ONSET and OFFSET of Ticagrelor in ESRD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the onset and offset of ticagrelor in patients with chronic kidney disease and end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED